These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6831912)

  • 1. Cyclophosphamide pretreatment in tumor cryotherapy: a comparison with alternative drugs.
    Cooper AJ; Fraser JD
    Cryobiology; 1983 Feb; 20(1):78-82. PubMed ID: 6831912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide pretreatment in tumor cryotherapy: a murine model.
    Cooper AJ; Powell JM; Perry S; Fraser JD
    Cryobiology; 1981 Dec; 18(6):577-84. PubMed ID: 7318481
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of epsilon-aminocaproic acid, cyclophosphamide and their combination on the growth of autochthonous sarcomas of mice induced by benzo(a)pyrene].
    Anikin IV; Tyndyk ML; Zabezhinskiĭ MA; Popovich IG; Anisimov VN; Pliss GB
    Vopr Onkol; 2014; 60(1):94-5. PubMed ID: 24772624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice.
    Hahn BH; Knotts L; Ng M; Hamilton TR
    Arthritis Rheum; 1975; 18(2):145-52. PubMed ID: 1131283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydrocortisone, cyclophosphamide, azathioprine and methotrexate on cutaneous delayed and arthus hypersensitivity in the rat.
    Mansour A; Nelson DS
    Int Arch Allergy Appl Immunol; 1979; 60(1):50-9. PubMed ID: 156699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression and murine polyomavirus infection.
    Rubino MJ; Walker D
    Virus Res; 1988 Jan; 9(1):1-10. PubMed ID: 2829462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in mice.
    Giuliani F; Di Marco A; Casazza AM; Savi G
    Eur J Cancer (1965); 1979 May; 15(5):715-23. PubMed ID: 510334
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D; Hilliard SL
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of sarcoma. A comparison of three regimens.
    Subramanian S; Wiltshaw E
    Lancet; 1978 Apr; 1(8066):683-6. PubMed ID: 76224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunity following cryosurgery or electrocauterization.
    Bagley DH; Faraci RP
    Natl Cancer Inst Monogr; 1978 Dec; (49):371-3. PubMed ID: 748796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching cancer chemotherapy by means of a computer simulation.
    Jean Y; De Traversay J; Lemieux P
    Int J Biomed Comput; 1994 Aug; 36(4):273-80. PubMed ID: 8002104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental use of antitumor preparations in low doses].
    Garkavi LKh; Kvakina EB; Mulatova AK; Taras'iants FM
    Vopr Onkol; 1981; 27(7):61-6. PubMed ID: 6791380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
    Cocconi G; Bisagni G; Bella M; Acito L; Anastasi P; Carpi A; Di Costanzo F; Frassoldati A; Mosconi A; Borrini A; Buzzi P
    Am J Clin Oncol; 1999 Dec; 22(6):593-600. PubMed ID: 10597744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.
    Kedar E; Ben-Aziz R; Epstein E; Leshem B
    Cancer Immunol Immunother; 1989; 29(1):74-8. PubMed ID: 2785003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the rhythm of cyclophosphamide administration on its antitumor action and the immune response of mice with methylcholanthrene sarcoma.
    Gordineko SP; Bergol'ts VM; Botsmanov KV
    Bull Exp Biol Med; 1975 Jan; 77(7):803-5. PubMed ID: 1115864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effect of cyclophosphamide and azathioprine on selected aspects of the canine blastogenic response.
    Ogilvie GK; Felsburg PJ; Harris CW
    Vet Immunol Immunopathol; 1988 Mar; 18(2):119-27. PubMed ID: 3388759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
    Smalley RV; Lefante J; Bartolucci A; Carpenter J; Vogel C; Krauss S
    Breast Cancer Res Treat; 1983; 3(2):209-20. PubMed ID: 6688538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.